Induction of cell proliferation in old rat liver can reset certain gene expression levels characteristic of old liver to those associated with young liver by Muhammad A. Chishti et al.
Induction of cell proliferation in old rat liver can reset certain
gene expression levels characteristic of old liver
to those associated with young liver
Muhammad A. Chishti & Namik Kaya &
Al-Bandary BinBakheet & Falah Al-Mohanna &
Malcolm H. Goyns & Dilek Colak
Received: 18 September 2011 /Accepted: 14 March 2012 /Published online: 4 April 2012
# The Author(s) 2012. This article is published with open access at Springerlink.com
Abstract During the past decade, it has become in-
creasingly clear that consistent changes in the levels of
expression of a small cohort of genes accompany the
aging of mammalian tissues. In many cases, these
changes have been shown to generate features that
are characteristic of the senescent phenotype. Previ-
ously, a small pilot study indicated that some of these
changes might be reversed in rat liver, if the liver cells
became malignant and were proliferating. The present
study has tested the hypothesis that inducing prolifer-
ation in old rat liver can reset the levels of expression
of these age-related genes to that observed in young
tissue. A microarray approach was used to identify
genes that exhibited the greatest changes in their ex-
pression during aging. The levels of expression of
these markers were then examined in transcriptomes
of both proliferating hepatomas from old animals and
old rat liver lobes that had regenerated after partial
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hepatectomy but were again quiescent. We have found
evidence that over 20 % of the aging-related genes had
their levels of expression reset to young levels by
stimulating proliferation, even in cells that had under-
gone a limited number of cell cycles and then become
quiescent again. Moreover, our network analysis indi-
cated alterations in MAPK/ERK and Jun-N-terminal
kinase pathways and the potential important role of
PAX3, VCAN, ARRB2, NR1H2, and ITGA5 that may
provide insights into mechanisms involved in longev-
ity and regeneration that are distinct from cancer.
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Introduction
It has become increasingly clear that changes in the
expression levels of certain genes accompany the ag-
ing of mammals. Over a decade ago, studies using the
differential display technique demonstrated that ap-
proximately 1 % of all active genes exhibit such age-
related changes, some increasing during aging and
others decreasing (Goyns et al. 1998; Salehi et al.
1996). An important observation from these early
studies was that the genes involved were consistent
from individual to individual and in some cases from
species to species (Goyns 2002). The advent of micro-
array technology allowed these general conclusions to
be confirmed, but also provided a far more rapid
identification of the genes exhibiting these age-
related changes. Most importantly, the microarray
studies demonstrated that the changes in gene expres-
sion were delayed in animals that had been subjected
to calorie restriction diets (Lee et al. 1999, 2000; Li et
al. 1997; Kume et al. 2010). As a calorie restriction
diet is the only experimental procedure that can con-
sistently extend life span in mammals (Masoro 1992),
these studies lend support to the hypothesis that
changes in gene expression levels are important in
the development of the senescent phenotype (Swindell
2008).
More recently, changes in gene expression have
been reported in a wide range of tissues, including
brain (Lu et al. 2004), kidney (Rodwell et al. 2004;
Kume et al. 2010), liver (Cao et al. 2001; Mori et al.
2007), fibroblasts(Ly et al. 2000), cardiac muscle (Lee
et al. 2002), and skeletal muscle (Welle et al. 2003).
These studies have studied species as diverse as mice
(Cao et al. 2001; Lee et al. 2002), monkeys (Kayo et
al. 2001), and humans (Welle et al. 2003). Increasing-
ly, these gene expression changes are being linked to
physiological aging (Rodwell et al. 2004; Zahn et al.
2006).
It is intriguing to question whether it is possible to
develop an intervention that could have an anti-aging
effect. The application of calorie restriction diets in
mice has already demonstrated that a general slowing
of these gene expression changes can be achieved
(Cao et al. 2001; Lee et al. 1999). Also, a small pilot
study has reported that some of the age-related
changes in gene expression observed in rat liver ap-
pear to be reversed in hepatoma cells derived from old
animals (Charlton et al. 1999; Tanaka et al. 2002). In
the latter study, it was not clear whether the reversal
effect was related to the hepatoma cells being malig-
nant or whether it was a result of the cells actively
proliferating.
In present study, we investigated the hypothesis that
stimulation of cell proliferation in old livers can reset
age-related gene expression levels to those observed in
young liver using a microarray approach. We analyzed
the transcriptomes of proliferating hepatoma cells,
regenerated old liver, and normal aging liver in a rat
model using a microarray of more than 27,000 anno-
tated genes from Celera and public repositories.
Hence, we explored possible molecular links between
regeneration, cancer, and longevity: common genes,




A colony of Sprague Dawley rats was maintained at
the King Fahad National Centre for Children's Cancer
and Research animal house, which is managed in
accordance with AALAS regulations. A total of 60
rats, including 30 young rats at the age of 5 months
and 30 old rats at the age of 22 months were used in
this study. These young rats were grouped as normal
young (denoted as NY), drug-induced hepatoma
(DY), and regenerating liver by partial hepatectomy
(RY), each consisting of 10 rats. Similarly, 30 old rats
were grouped as normal old (NO), drug-induced
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hepatoma (DO), and regenerating liver by partial hep-
atectomy (RO), each consisting of 10 rats.
Ten rats from the young and old age groups were
subjected to partial hepatectomy. Briefly, a midline
ventral abdominal skin incision was made, and a small
bolster was placed under the thorax causing the liver
to fall slightly forward away from the diaphragm;
then, the ligaments attaching the liver to the dia-
phragm were cut down. A piece of gauze was placed
near the incision, and the left lateral and median lobes
were moved out from the abdominal cavity. These
lobes were lifted vertically, blood vessels were tied
then laid on the gauze, and a cut was made to bleed on
the gauze, not into the abdominal cavity, and finally
transected. The bolster was removed, and the skin
incisions were closed (Wayneforth 1980). The remain-
ing liver lobes were allowed to undergo the regenera-
tion process, which was completed within 1 month, by
which time the liver cells had again become quiescent.
This was confirmed by a histological analysis of sec-
tions from the liver. The rats were sacrificed after
1 month of partial hepatectomy, and samples were col-
lected from four rats in each group.
In parallel, young and old rats (10 each) were treated
with diethylnitrosoamine (200 mg/kg), which was
injected intraperitoneally to induce the formation of a
hepatoma (Ito et al. 1989). Tumor formation became
apparent within 4 weeks. The rats were sacrificed, and
samples were collected. All tissues were snap frozen and
stored at –80 °C until required for RNA isolation. Small
pieces of tissue were also removed from the regenerated
lobes and hepatoma foci at the same time, subjected to
formalin fixation, and examined histologically after he-
matoxylin and eosin staining. Samples were collected
from a minimum of four rats in each group. We used
four individual animals in each group (DO,DY, RO, RY,
NO, and NY) for further study.
RNA isolation
RNAwas prepared from the rat tissue samples using the
Trizol protocol (Invitrogen, Carlsbad, CA, USA). Total
RNA quality and quantities were determined by mea-
suring the absorbance spectra on a UV/vis spectropho-
tometer, the NanoDrop® ND-1000 Spectrophotometer
(Nanodrop Inc., Wilmington, DE, USA), and further
analyzed by an RNA 6000 Nano Assay using the 2100
Bioanalyzer (Agilent Technologies, Santa Clara, USA).
The undegraded, higher-quality RNA was processed
further for RT-PCR and microarray experiments.
Microarray hyridization
Whole-genome gene expression profiling of 24 sam-
ples from hepatoma cells (DO, DY; n08), regenerated
liver (RO, RY; n08), and normal liver (NO, NY; n08)
using Applied Biosystems Rat Genome Survey Micro-
array (Applied Biosystems, Foster City, CA, USA)
contains more than 27,000 gene sequences based on
60-mer oligonucleotide probes. Digoxigenin-UTP-
labeled cRNA was generated and amplified from
2 μg total RNA from each sample using applied Bio-
systems Chemiluminescent RT-IVT labeling kit v 1.0
(Applied Biosystems, Foster City, CA, USA) follow-
ing the manufacturer's protocol. Array hybridization
was performed for 16 h at 55 °C. Chemiluminescence
detection, image acquisition, and analysis were per-
formed using Applied Biosystems Chemilumines-
cence Detection Kit and the Applied Biosystems
1700 Chemiluminescent Microarray Analyzer (Ap-
plied Biosystems, Foster City, CA, USA), following
the manufacturer's protocol.
Microarray data analysis
Images were auto-gridded, the chemiluminescent
signals were quantified, and the background sub-
tracted using the Applied Biosystems 1700 Chemi-
luminescent Microarray Analyzer software v 1.1.
For transcriptome analysis, detection thresholds
were used following the manufacturer's recommen-
dations. Detection threshold was set as S/N >3 and
quality flag <5,000. Various Bioconductor pack-
ages were used for normalization and determination
of differentially expressed genes (Gentleman et al.
2004). Significantly modulated genes were defined
as those with absolute fold change >2.0 and an
analysis of variance (ANOVA) p value <0.05. Hu-
man hepatocellular carcinoma (HCC) datasets from
independent studies were analyzed as described
previously (Colak et al. 2010). The hierarchical
clustering of differentially expressed genes using
Pearson's correlation with average linkage cluster-
ing was performed using the TIGR Multi Experi-
ment Viewer (Saeed et al. 2003), and heatmaps
were generated with red and green indicating high
and low expression, respectively.
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Functional annotation and biological term enrich-
ment analysis was performed by using the protein anal-
ysis through evolutionary relationships (PANTHER)
classification system (Thomas et al. 2003). For each
molecular function, biological process, or pathway term,
PANTHER calculates the number of genes identified in
that category in both the list of differentially regulated
genes and a reference list containing all the probe sets
present on the AB Human Genome Survey Microarray
and compares these results using the binomial test to
determine if there are more genes than expected in the
differentially regulated list (Thomas et al. 2006). Over-
representation was defined by a p value <0.05. Func-
tional pathway and gene interaction network analyses
were executed using Ingenuity Pathways Analysis (IPA)
6.3 (Ingenuity Systems,Mountain View, CA). Statistical
analyses were performed with the MATLAB software
packages (Mathworks, Natick, MA, USA), R/Biocon-
ductor, and PARTEK Genomics Suite (Partek Inc., St.
Louis, MO, USA).
Real-time RT-PCR
In order to validate our microarray results, confirma-
tory real-time RT-PCR was performed using the ABI
7500 Sequence Detection System (ABI, Foster City,
CA, USA). For this purpose, 50 ng total RNA pro-
cured from the same microarray study samples was
transcribed into cDNA using Sensiscript Kit (QIA-
GEN Inc., Valencia, CA, USA) according to the man-
ufacturer's recommendations. Eight differentially
expressed genes were randomly selected and primers
designed using Primer3 software (Table 1). After
primer optimization, the PCR assays were performed
in 6 μl of the cDNA using the QIAGEN QuantIT
SyBR Green Kit, employing GAPDH as the endoge-
nous control gene. All reactions were conducted in
triplicates, and the data were analyzed using the delta
delta CT method (Livak and Schmittgen 2001).
Results
Global gene expression profiling of normal aging
liver, hepatoma, and regenerated old liver
We analyzed whole-genome mRNA expression profil-
ing of hepatoma cells, regenerated liver from old rats,
and normal liver of both young and old rats using
Applied Biosystems Rat Genome Survey microarray
which includes more than 27,000 annotated genes.
First, we indentified normal aging signature genes by
comparing the transcriptomes of normal young and
old livers. The ANOVA identified 1,300 probes
(corresponding to 397 up- and 519 downregulated
genes) as differentially expressed in normal old com-
pared to normal young (p value <0.05 and absolute
fold change of >2.0). The levels of expression of these
genes were then compared to the hepatomas derived
from old liver and the regenerated old liver by using
overlapping gene lists (Fig. 1a). When comparing two
groups of samples to identify genes differentially
expressed in a given group, we used p value and the
fold change (FC) between two groups as the cutoff
criteria. If the p value is <0.05 and the absolute FC
between the groups is >2.0, the corresponding gene
was considered differentially expressed between the
two groups. Each circle in the Venn diagram repre-
sents the differential expression between two “treat-
ment” types (Fig. 1a). The red circle (left) shows the
1,300 normal aging genes that are differentially
expressed between NO and NY; 142 and 154 of those
genes were also differentially expressed in regenerated
liver (RO) and hepatomas from old liver, respectively,
Table 1 Nucleotide sequences
used in real-time RT-PCR vali-
dation of randomly selected
genes identified by microarray
analysis
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Fig. 1 a Venn diagram indicating the significantly regulated
gene overlaps for three comparisons. b–d Heatmaps of genes in
the intersection I, II, and III indicated in the Venn diagram (Fig.
1a), respectively. Gene symbols are listed on the right. In
heatmaps, rows represent genes, and columns represent samples
from DO (hepatoma in old), RO (regeneration in old), NO
(normal old), and NY (normal young) groups. Genes are clus-
tered using row normalized signals and mapped to the [−3,3]
interval. Red and green represent high and low expression
values, respectively
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47 of which were common to all comparisons (Fig. 1a,
listed in Table 2). It is clearly seen from the heatmaps
that over 90 % of genes commonly dysregulated in
aging and hepatoma as well as in regeneration have
similar levels of expression as in normal young liver
(NY), but not from normal old liver (NO) (Fig. 1b–d),
where red indicates high levels of expression and green
indicates low levels of expression. Intriguingly, we iden-
tified 95 aging genes that are significantly dysregulated
in the regenerated old liver; however, their expressions
in the regenerated old liver were reversed (Fig. 1a, re-
gion III, and Fig. 1d). This excludes the 47 aging genes
that were also dysregulated in hepatomas from old liver
(Fig. 1a, region I). Indeed, as in the hepatoma, expres-
sion levels of over 90 % of aging genes in the regen-
erated old liver were also reset to those seen in the
normal young liver (Fig. 1d). The heatmap of those
genes were shown in Fig. 1d and listed in Table 3.
Importantly, this set of genes corresponds to ones that
are exclusively due to cells that had undergone prolifer-
ation (in old liver), but not due to cells undergoing
malignancy (hepatoma) and have similar level of ex-
pression to those seen in the normal young liver.
Gene ontology analyses of aging and regenerated old
liver transcriptome
To delineate which biological processes are significantly
overrepresented in normal aging and regenerated signa-
ture genes, we performed gene ontology and biological
term enrichment analyses using both the PANTHER
classification system and the Ingenuity Pathway Analysis
(IPA). Intriguingly, genes related to immune response,
cell adhesion, nervous system and development, and
response to stress were found to be activated with aging.
On the other hand, genes involved with lipid metabolism,
cellular growth and maintenance, protein synthesis, and
cellular communication were downregulated. The
regeneration-specific genes, however, were mainly asso-
ciated with lipid metabolism, mRNA transcription and
regulation, protein modification, protein phosphoryla-
tion, cell morphology, cellular development, small mole-
cule biochemistry, and cellular growth and proliferation.
Thus, the genes and processes activated or repressed by
aging were conversely regulated in the regenerated liver.
We next sought to examine the overrepresented bio-
logical processes of 95 significantly dysregulated genes
Table 2 Selected differentially up- or downregulated genes in both regenerated (RO) liver and hepatomas (DO) from old liver whose
expression levels were also reset to those seen in normal young (NY) liver (Fig. 1a, region I)
Gene Gene name NY/NOa DO/NOb RO/NOb
Dixdc1 DIX domain containing 1 −2.9 −2.7 −3.4
Ankk1 Ankyrin repeat and kinase domain containing 1 −3.0 −2.3 −3.2
Esm1 Endothelial cell-specific molecule 1 −5.2 −3.4 −3.2
Gpc2 Glypican 2 −3.7 −3.6 −3.1
Rhobtb2 Rho-related BTB domain containing 2 −2.1 −2.8 −2.8
Rpl28 Ribosomal protein L28 −2.9 −3.3 −2.7
Dlx1 Distal-less homeobox 1 −2.7 −2.4 −2.6
Mbtps2 Membrane-bound transcription factor peptidase, site 2 −2.5 −2.2 −2.6
LACS L-NAME induced actin cytoskeletal protein −3.0 −2.6 −2.5
RGD1565996 Similar to DnaJ homolog subfamily B member 6 (Heat shock protein J2) −2.8 −3.0 −2.5
Tgm3 Transglutaminase 3, E polypeptide −3.1 −3.5 −2.5
Olr1393 Olfactory receptor 1393 −2.1 −2.2 −2.4
Scn5a Sodium channel, voltage-gated, type V, alpha polypeptide −3.3 −2.3 −2.1
Eml4 Echinoderm microtubule associated protein like 4 3.6 2.7 2.2
Nrp1 Neuropilin 1 2.4 2.5 2.4
RGD1562100 Similar to ADP-ribosylation factor interacting protein 2 (arfaptin 2) 3.0 3.1 3.1
Caskin1 CASK-interacting protein 1 3.6 3.4 3.4
Cap350 Centrosome-associated protein 350 8.1 3.5 3.4
a Fold change (FC) was calculated between the mean values of NO (normal old) and NY (normal young)
b Fold change (FC) was calculated between the mean values of NO (normal old) and DO (hepatoma) as well as RO (regenerated)
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Table 3 Top 38 genes that were most significantly dysregulated in regenerated old liver (excluding genes that are shared in hepatomas
from old liver) whose expressions were reset to the normal young status (Fig. 1a, region III)
Gene symbol Gene name Biological process FC NY/NOa FC RO/NOb
Cspg2 Chondroitin sulfate
proteoglycan 2
Cell motility | signal transduction | extracellular matrix
protein-mediated signaling; cell proliferation and dif-





Synaptic transmission | transport | neuronal activities −18.9 −4.8
Tll2 Tolloid-like 2 Proteolysis; signal transduction | protein metabolism and
modification | ligand-mediated signaling; develop-
mental processes | mesoderm development | cell com-
munication | skeletal development
−3.6 −3.1
Zbtb16 Zinc finger and BTB
domain containing 16
Nucleoside, nucleotide and nucleic acid metabolism |
mRNA transcription
−2.4 −2.9
RGD1310257 Similar to RIKEN cDNA
6330408A02 gene
Protein metabolism and modification | proteolysis;
developmental processes | neurogenesis; cell
proliferation and differentiation | ectoderm
development
−2.6 −2.9
Arrb2 Arrestin, beta 2 Cell surface receptor-mediated signal transduction | sig-
nal transduction | G protein-mediated signaling; intra-




Tumor suppressor | cell cycle | cell cycle control; cell
proliferation and differentiation; oncogenesis
−3.2 −2.6
Extl2 Exotoses (multiple)-like 2 Other polysaccharide metabolism; protein metabolism
and modification | protein glycosylation | carbohydrate
metabolism
−3.8 −2.6
Slc25a32 Solute carrier family 25,
member 32
Small molecule transport | transport −2.2 −2.5




deaminase 1 (isoform M)
Nucleoside, nucleotide, and nucleic acid metabolism |
purine metabolism
−2.1 −2.5
RGD1309049 Similar to RIKEN cDNA
4933415F23
Protein phosphorylation; protein targeting and
localization | protein metabolism and modification |
protein targeting | protein modification
−2.2 −2.4
Slc25a41 Solute carrier family 25,
member 41
Small molecule transport | transport −2.3 −2.4
LOC500105 Similar to contactin
associated protein-like 2
isoform a
Synaptic transmission | signal transduction | cell
communication | cell adhesion-mediated signaling; cell
adhesion; neuronal activities
−2.3 −2.3
Mlph Melanophilin General vesicle transport | intracellular protein traffic −3.0 −2.3
Nek11 NIMA (never in mitosis
gene a)-related kinase 11
Protein metabolism and modification | protein





Tumor suppressor | cell cycle | cell cycle control; cell
proliferation and differentiation; oncogenesis
−2.9 −2.2
Klk6 Kallikrein 6 Proteolysis | protein metabolism and modification −2.2 −2.1
Gja5 Gap junction membrane
channel protein alpha 5
Signal transduction −2.6 −2.1
Il21r Interleukin 21 receptor Natural killer cell-mediated immunity | immunity
and defense
−2.4 −2.1
Clca3 Chloride channel calcium
activated 3
ATP synthesis coupled proton transport −2.3 −2.1
Akr1c6 Aldo-keto reductase family
1, member C6
Steroid hormone metabolism | steroid metabolism | fatty
acid biosynthesis; lipid, fatty acid, and steroid
metabolism | fatty acid metabolism | lipid, fatty acid,
and steroid metabolism
2.8 2.1
AGE (2013) 35:719–732 725
shared in the regenerated liver and in normal aging,
however, in the opposite direction. The biological pro-
cesses of those genes include signal transduction (21%),
protein metabolism and modification (14 %), develop-
mental process (13 %), transport, and cellular differen-
tiation and proliferation (Fig. 2a). The most significantly
enriched biological process categories include ectoderm
and mesoderm development, developmental process,
small molecule transport, and cell proliferation and dif-
ferentiation (p value <0.05). Consistent with the catego-
ries identified by PANTHER, the IPA functional
analysis also revealed cellular movement, embryonic
development, lipid metabolism, small molecule bio-
chemistry, cellular growth and proliferation, tissue de-
velopment, and cellular development as significantly
enriched functional categories (Fig. 2b).
Gene interaction network analysis of aging genes reset
to young age by regeneration
To obtain a deeper insight into the interaction network
and altered pathways, we mapped the 95 aging genes
Table 3 (continued)
Gene symbol Gene name Biological process FC NY/NOa FC RO/NOb
Rshl2 Radial spokehead-like 2 Signal transduction; intracellular protein traffic; protein
targeting and localization; miscellaneous
2.1 2.3
Pde8b Phosphodiesterase 8B Nucleoside, nucleotide and nucleic acid metabolism |
metabolism of cyclic nucleotides; signal transduction
2.7 2.3
Cyp3a13 Cytochrome P450, family 3,
subfamily a, polypeptide
13
Steroid hormone metabolism; electron transport | steroid
metabolism | lipid, fatty acid, and steroid metabolism
30.2 2.3
Tubg1 Tubulin, gamma 1 Cell motility | chromosome segregation; cell structure
and motility | cell structure; cell structure and motility |
mitosis | intracellular protein traffic; cell cycle
2.5 2.5
Kb24 Type II keratin Kb24 Ectoderm development; cell structure and motility | cell
structure | developmental processes
2.2 2.5
Pax3 Paired box gene 3 Nucleoside, nucleotide, and nucleic acid metabolism |
mRNA transcription regulation; developmental
processes | segment specification; neurogenesis |
ectoderm development
2.4 2.5
Gpr85 G protein-coupled receptor
85
Cell surface receptor-mediated signal transduction | sig-
nal transduction | G protein-mediated signaling
2.7 2.7
Fut11 Fucosyltransferase 11 Protein metabolism and modification | protein




Lipid, fatty acid, and steroid metabolism | other neuronal
activity | phospholipid metabolism; neuronal activities
2.1 2.7
Nsddr Neural stem cell-derived
dendrite regulator
Biological process unclassified 2.3 3.0
Nr1h2 Nuclear receptor subfamily
1, group H, member 2
Transcription | regulation of transcription, DNA-
dependent | negative regulation of transcription | cel-
lular lipid metabolic process | positive regulation of
transcription, DNA-dependent | retinoic acid receptor
signaling pathway
3.9 3.1
Ptk6 PTK6 protein tyrosine
kinase 6
Protein phosphorylation; signal transduction | protein
metabolism and modification | protein modification |
intracellular signaling cascade; oncogenesis
2.7 3.3
Itga5 Integrin alpha 5 Cell adhesion 3.0 3.4
Olr813 Olfactory receptor 813 Cell surface receptor-mediated signal transduction | sig-
nal transduction | G protein-mediated signaling; sen-
sory perception | olfaction | chemosensory perception
2.3 3.8
Slc6a6 Solute carrier family 6 Transport | small molecule transport; transport |
extracellular transport and import
3.9 5.0
a Fold change (FC) was calculated between the mean values of NO (normal old) and NY (normal young)
b Fold change (FC) was calculated between the mean values of NO (normal old) and DO (hepatoma) as well as RO (regenerated)
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whose expression was set to young age by regeneration
to gene networks using the ingenuity knowledge base.
These genes were mapped primarily to top networks
(Fig. 2c) related to, among others, cellular movement,
embryonic development, cellular growth and prolifera-
tion, tissue development, lipid metabolism, and small
molecule biochemistry. Our gene network analysis indi-
cated important roles ofPAX3,E2F1, ITGA5,MAPK, and
Fig. 2 Functional and network analyses of aging and regener-
ated liver transcriptome. PANTHER pie chart of biological
processes (a), significantly enriched functional categories (b),
and gene interaction network (c) analysis of regeneration-
specific up/downregulated genes that are also common to nor-
mal aging genes, and whose expressions were reset to the
normal young status. b X-axis indicates the significance (-log
p value) of the functional association that is dependent on the
number of genes in a class as well as biologic relevance. c Nodes
represent genes, with their shape representing the functional
class of the gene product, and edges indicate biological relation-
ship between the nodes (see legend). Green indicates down-
regulated; red, upregulated in RO (regenerated). The color
intensity is correlated with fold change. Straight lines are for
direct gene-to-gene interactions, dashed lines are for indirect
ones
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VCAN that are interacting with many other genes that we
have identified in this study.
Validation of the results in independent HCC datasets
and comparison to calorie restriction studies
As a validation of our results, we re-analyzed three
independently performed microarray datasets for human
HCC (Wurmbach et al. 2007; Boyault et al. 2007; Mas
et al. 2009). The comparison of our rat HCC genes
(human orthologous) with the re-analyzed human
HCC datasets revealed a significant number of genes
in common (p value <0.001). Furthermore, we obtained
consistent results with two independent studies of DEN-
induced HCC in rats (Perez-Carreon et al. 2006; Liu et
al. 2009). The functional and gene ontology analyses of
all validation datasets revealed a significant number of
overrepresented functional categories in common with
our results. Of note, cell death, cancer, cellular develop-
ment, cellular growth and proliferation, organismal
development, transport, and cell cycle came up as sig-
nificantly enriched categories in both the validation
datasets and our analyses.
To further validate, we compared our results with
independently performed microarray studies for aging
and calorie restriction. Most recently, Hong et al. (2010)
gathered genes related to aging and calorie restriction
(CR) from numerous published studies and from micro-
array datasets in the GEO repository. We found that a
significant number of our aging genes were in common
with our analysis results (p value <0.05). Furthermore, a
significant number of over-represented gene ontology
(GO) terms in aging from our analysis were retained in
the validation set. For example, immune response, cell
adhesion, lipid metabolism, cellular development, ner-
vous system development and function, cell-to-cell sig-
naling, and skeletal and muscular system development
and function come up as significantly enriched GO
categories in both the validation and our analysis.
Hence, the similarities between our results and the inde-
pendent validation sets argue against random chance
accounting for the observed enrichment of these func-
tional categories and pathways.
Validation of selected differentially expressed genes
using real-time RT-PCR
We used quantitative real-time RT-PCR to validate our
microarray results for eight randomly selected genes
(E2f5, Cep350, Nrp1, Esm1, Cltb, Caskin1, Wit3, and
Ube2l6) (Table 4). A significant correlation existed
between the microarray and real-time RT-PCR results
(r>0.74, p value <0.03). We also validated expression
levels of another set of six randomly selected differ-
entially regulated genes (Pbsn, Cdh13, Lum, Nid2,
Dcn, Slc22a5) in our earlier study (Colak et al.
2010). In all cases, a high concordance existed be-
tween the microarray and real-time RT-PCR results
thus demonstrating the reliability of our gene expres-
sion measurements.
Discussion
The present study sought to investigate if the prolifer-
ation in old rat liver can reset the levels of expression
of aging-related genes to that observed in young tissue
using global gene expression profiling. We developed
a rat model of liver regeneration post-hepatectomy
(return to quiescence), as well as liver cells undergo-
ing malignant transformation, and compared them to
normal liver using a comprehensive microarray of
27,000 publicly available and Celera annotated rat
genes. We have found evidence that over 20 % of the
aging-related genes had their levels of expression reset
to young levels by stimulating proliferation, even in
cells that had undergone a limited number of cell cycles
and then become quiescent again. Importantly, we iden-
tified genes and pathways significantly altered with
aging and regeneration that are distinct from cancer.
Aging is a complex process characterized by a
gradual and progressive decay of biochemical and
physiological functions of most organs. Our data
revealed that genes associated with immune and stress
response were activated with aging, whereas genes
associated with lipid metabolism, cellular growth and
maintenance, protein synthesis, and cellular commu-
nication were downregulated, consistent with other
independent studies, such as gene expression in hu-
man retina (Yoshida et al. 2002), gene expression
profiling of aging rat liver (Tollet-Egnell et al. 2001),
age-associated changes in gene expression in human
liver (Thomas et al. 2002), and mouse transcriptome
(Hong et al. 2010; Schumacher et al. 2008). The
functional pathways were also consistent with previ-
ous studies. However, the novelty of our approach is
that we identified a novel group of genes and altered
pathways involved in regeneration and hepatoma as
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well as in aging and found genes differentially regu-
lated in both regenerated and hepatomas from old
liver, as well as uniquely dysregulated genes in hepa-
toma and regenerated whose expressions were reset to
that seen in normal young. Intriguingly, the compari-
son of normal aging genes with the significantly dys-
regulated genes in the regenerated old liver revealed
that the expression levels of over 90 % of shared genes
had displayed similar levels to those seen in the nor-
mal young liver than old liver. This occurred in hep-
atoma cells that were actively proliferating (Charlton
et al. 1999) and, more importantly, also in cells from
regenerated liver lobes that had undergone a limited
number of cell divisions and then resumed a quiescent
state. The gene ontological analysis revealed that the
regeneration-specific genes were mainly associated
with lipid metabolism, mRNA transcription and regu-
lation, protein modification, protein phosphorylation,
cell morphology, cellular development, small mole-
cule biochemistry, and cellular growth and prolifera-
tion. Thus, the genes and processes activated or
repressed by aging were conversely regulated in the
regenerated liver.
CR diet has been shown to have effects on lifespan
prolongation, mitochondrial autophagy, cell adapta-
tion to hypoxia, and antineoplastic effects (Li et al.
1997; Cao et al. 2001). Hence, we investigated if there
are any similarities between calorie restriction and
regeneration-related gene expression changes, as both
have demonstrated a reversal of gene expression
changes due to aging. Studies on CR-related lon-
gevity indicate a number of genes, including silent in-
formation regulator 2 (Sir2), Sirtuin 1, forkhead box
(FOXO1), that are involved in antineoplastic effects;
whereas, FoxM1B transcription factors prevent age-
related proliferation defects (Wang et al. 2001; Nasarre
et al. 2010; Yamaza et al. 2010). Recently, proteomic
profiling was done in aging rat white adipose tissue, and
calorie restriction reversed the aging-related protein al-
teration. Calorie restriction improves the oxidative
stress, cellular and energy metabolism, iron storage,
and antioxidant affects (Valle et al. 2010). The compar-
ison of CR and our regenerated-related genes that reset
the aging genes revealed over-representation of genes
related to lipid metabolism, cellular growth and prolif-
eration, transcription, cell adhesion, and response to
stimulus (Hong et al. 2010).
Our functional pathway and network analysis of
aging genes whose expression was reversed by regen-
eration indicated alterations in MAPK/ERK and Jun-
N-terminal kinase (JNK) pathways. Recent studies
have identified the JNK pathway as a regulator of
insulin/insulin-like growth factor signaling and influ-
encing growth, metabolism, stress tolerance, and re-
generation (Wang et al. 2005, 2003; Karpac et al.
2009). Interestingly, moderate activation of JNK sig-
naling resulted in increased stress tolerance and ex-
tended life span in various organisms (Wang et al.
2005, 2003). Moreover, our network analysis also
indicated potential important roles of PAX3, VCAN,
ARRB2, ITGA5, and NR1H2 that are interacting with
many other genes that we have identified in this study.
These genes are known to be involved in proliferation,
organismal development, and cell adhesion in a wide
variety of cell types (Anderson et al. 2001; Matsumura
et al. 2003; Conboy et al. 2011). Interestingly, liver X
Table 4 Validation of selected differentially expressed genes using real-time RT-PCR
Gene symbol Description Hepatoma (DO/NO) Regenerated (RO/NO) Normal aging (NO/NY)
qRTPCR Microarray qRTPCR Microarray qRTPCR Microarray
Caskin1 Cask-interacting protein 1 10.1 3.4 10.3 3.4 −4.9 −3.6
Wit3.0 Wound inducible transcript 3.0 6.8 1.4 4 1.5 −3.9 −1.6
Cltb Clathrin, light polypeptide (Lcb) 7.4 1.6 4.6 2.5 −1.7 −1.8
Nrp1 Neuropilin 1 1.4 2.5 3.1 2.4 −2.3 −2.5
Cep350 Centrosome-associated protein 350 1.4 3.5 2.5 3.4 −2.3 −8.1
Esm1 Endothelial cell-specific molecule 1 −1.8 −3.4 −1.8 −3.2 10 5.2
Ube2l6 Ubiquitin-conjugating enzyme E2L 6 −2.5 −3.8 −3.3 −2.6 1.8 3
E2f5 E2F transcription factor 5 −1.4 −2.5 −1.8 −1.9 1.4 4.3
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receptor beta (LXR-β) is a member of the nuclear
receptor family of transcription factors and encoded
by the NR1H2 gene (nuclear receptor subfamily 1,
group H, member 2). LXR-β is a close human homo-
logue of daf-12, a regulator of nematode longevity,
and is a key regulator of macrophage function, con-
trolling transcriptional programs involved in lipid ho-
meostasis and inflammation (Gerisch et al. 2001; Ly et
al. 2000; Gems et al. 1998; Chang et al. 2008). It is
therefore possible that these genes were influential in
producing the changes in gene expression we have
observed as a result of inducing proliferation in old
liver and hence warrant further study.
In conclusion, to our knowledge, this is the first
study to examine global gene expression patterns in
normal aging and regenerated old liver differentiated
from hepatic liver and demonstrates that by inducing
cells to proliferate, it is possible to reset the gene
expression levels in old rat liver to that observed in
normal young liver for many of the differentially
expressed genes. This occurred in malignant cells that
were actively proliferating and also in cells from
regenerated liver lobes that had undergone a limited
number of cell divisions and then resumed a quiescent
state. Intriguingly, the cells do not need to be actively
proliferating to maintain the reset state. It is unknown
which aspect of cell proliferation is responsible for this
effect. However, if this can be identified in future
research, then it may prove possible to develop an
intervention that can produce an anti-aging effect.
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